Blood-based metabolic signatures in Alzheimer's disease

INTRODUCTION: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers. METHODS: We included 127 Alzheimer's disease (AD) patients and 121 control subjects with cerebrospinal fluid biomarker-confirmed diagnosis (cutoff tau/amyloid β peptide 42: 0.52). Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: de Leeuw, Francisca A., Peeters, Carel F.W., Kester, Maartje I., Harms, Amy C., Struys, Eduard A., Hankemeier, Thomas, van Vlijmen, Herman W.T., van der Lee, Sven J., van Duijn, Cornelia M., Scheltens, Philip, Demirkan, Ayşe, van de Wiel, Mark A., van der Flier, Wiesje M., Teunissen, Charlotte E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607205/
https://www.ncbi.nlm.nih.gov/pubmed/28951883
http://dx.doi.org/10.1016/j.dadm.2017.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607205/
https://www.ncbi.nlm.nih.gov/pubmed/28951883
http://dx.doi.org/10.1016/j.dadm.2017.07.006

Ejemplares similares